Birabresib Uses, Dosage, Side Effects and more
Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)).
| Trade Name | Birabresib |
| Generic | Birabresib |
| Birabresib Other Names | Birabresib |
| Type | |
| Formula | C25H22ClN5O2S |
| Weight | Average: 491.99 Monoisotopic: 491.1182738 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
